{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:15:37Z","timestamp":1792721737291,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171490"],"award-info":[{"award-number":["82171490"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neuropharm.2025.110523","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T14:53:44Z","timestamp":1747666424000},"page":"110523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effects of inhibiting the orexin system on nicotine reward memory and fear memory"],"prefix":"10.1016","volume":"276","author":[{"given":"Pan","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2025.110523_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2008.06.060","article-title":"Role of lateral hypothalamic orexin neurons in reward processing and addiction","volume":"56","author":"Aston-Jones","year":"2009","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110523_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bph.12639","article-title":"Orexin\/hypocretin role in reward: implications for opioid and other addictions","volume":"172","author":"Baimel","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110523_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084090","article-title":"Targeting the reconsolidation of licit drug memories to prevent relapse: focus on alcohol and nicotine","volume":"22","author":"Barak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110523_bib4","unstructured":"Baumann CR, Bassetti CL. Hypocretins (Orexins): Clinical Impact of the Discovery of a Neurotransmitter. (1087-0792 (Print))."},{"key":"10.1016\/j.neuropharm.2025.110523_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2018.04.005","article-title":"Sex- and age-dependent effects of orexin 1 receptor blockade on open-field behavior and neuronal activity","volume":"381","author":"Blume","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110523_bib6","unstructured":"Bortz DM, Gazo KL, Grace AA. The Medial Septum Enhances Reversal Learning via Opposing Actions on Ventral Tegmental Area and Substantia Nigra Dopamine Neurons. (1740-634X (Electronic))."},{"issue":"52","key":"10.1016\/j.neuropharm.2025.110523_bib7","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.0507480102","article-title":"Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior","volume":"102","author":"Boutrel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"38","key":"10.1016\/j.neuropharm.2025.110523_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202405354","article-title":"Hypocretin-1\/Hypocretin receptor 1 regulates neuroplasticity and cognitive function through hippocampal lactate homeostasis in depressed model","volume":"11","author":"Chen","year":"2024","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110523_bib9","doi-asserted-by":"crossref","DOI":"10.4172\/2329-6488.1000273","article-title":"Neuroanatomical relationships between orexin\/hypocretin-containing neurons\/nerve fibers and nicotine-induced c-fos-activated cells of the reward-addiction neurocircuitry","volume":"5","author":"Dehkordi","year":"2017","journal-title":"Journal of alcoholism and drug dependence"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110523_bib10","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pbb.2011.06.019","article-title":"Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats","volume":"99","author":"Fang","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110523_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pharep.2018.12.013","article-title":"Orexin type-2 receptor blockade prevents the nicotine-induced excitation of nucleus accumbens core neurons in rats: an electrophysiological perspective","volume":"71","author":"Fartootzadeh","year":"2019","journal-title":"Pharmacol. Rep. : PR"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110523_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.biopsych.2013.06.012","article-title":"The hypocretin\/orexin receptor-1 as a novel target to modulate cannabinoid reward","volume":"75","author":"Flores","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110523_bib13","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/npp.2014.146","article-title":"The hypocretin\/orexin system mediates the extinction of fear memories","volume":"39","author":"Flores","year":"2014","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110523_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tins.2015.06.005","article-title":"Orexins and fear: implications for the treatment of anxiety disorders","volume":"38","author":"Flores","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110523_bib15","unstructured":"Gentile TA, Simmons SA-O, Barker DJ, Shaw JK, Espa\u00f1a RA, Muschamp JW. Suvorexant, an Orexin\/hypocretin Receptor Antagonist, Attenuates Motivational and Hedonic Properties of Cocaine. (1369-1600 (Electronic))."},{"key":"10.1016\/j.neuropharm.2025.110523_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2020.06.006","article-title":"Opposite regulation of conditioned place preference and intravenous drug self-administration in rodent models: motivational and non-motivational examples","volume":"116","author":"Green","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110523_bib17","unstructured":"Haghparast A, Fatahi Z, Arezoomandan R, Karimi S, Taslimi Z, Zarrabian S. Functional Roles of Orexin\/hypocretin Receptors in Reward Circuit. (1875-7855 (Electronic))."},{"issue":"7058","key":"10.1016\/j.neuropharm.2025.110523_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature"},{"issue":"49","key":"10.1016\/j.neuropharm.2025.110523_bib19","doi-asserted-by":"crossref","first-page":"19480","DOI":"10.1073\/pnas.0808023105","article-title":"Insular hypocretin transmission regulates nicotine reward","volume":"105","author":"Hollander","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110523_bib20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.biopsych.2022.06.027","article-title":"Orexin reserve: a mechanistic framework for the role of orexins (hypocretins) in addiction","volume":"92","author":"James","year":"2022","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110523_bib21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.biopsych.2018.07.022","article-title":"Increased number and activity of a lateral subpopulation of hypothalamic orexin\/hypocretin neurons underlies the expression of an addicted state in rats","volume":"85","author":"James","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110523_bib22","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/endo.141.10.7707","article-title":"Nicotine up-regulates expression of orexin and its receptors in rat brain","volume":"141","author":"Kane","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2025.110523_bib23","unstructured":"Kato TM, Fujimori-Tonou N, Mizukami H, Ozawa K, Fujisawa S, Kato T. Presynaptic Dysregulation of the Paraventricular Thalamic Nucleus Causes Depression-like Behavior. (2045-2322 (Electronic))."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110523_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173967","article-title":"The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking","volume":"12","author":"Khoo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110523_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114741","article-title":"The effects of a dual orexin receptor antagonist on fear extinction memory and sleep in mice: implications for exposure therapy","volume":"458","author":"Kobayashi","year":"2024","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110523_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114741","article-title":"The effects of a dual orexin receptor antagonist on fear extinction memory and sleep in mice: implications for exposure therapy","volume":"458","author":"Kobayashi","year":"2024","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110523_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/fcp.12249","article-title":"SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats","volume":"31","author":"Kordi Jaz","year":"2017","journal-title":"Fund. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110523_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-010-1792-0","article-title":"Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA","volume":"209","author":"LeSage","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110523_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105317","article-title":"Orexin 2 receptor in the nucleus accumbens is critical for the modulation of acute stress-induced anxiety","volume":"131","author":"Li","year":"2021","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110523_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41398-021-01566-6","article-title":"Neural substrates of propranolol-induced impairments in the reconsolidation of nicotine-associated memories in smokers","volume":"11","author":"Lin","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110523_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw009","article-title":"Effects of trace amine-associated receptor 1 agonists on the expression, reconsolidation, and extinction of cocaine reward memory","volume":"19","author":"Liu","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110523_bib32","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.biopsych.2021.12.018","article-title":"Convergent coding of recent and remote fear memory in the basolateral amygdala","volume":"91","author":"Liu","year":"2022","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110523_bib33","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/s41380-022-01448-3","article-title":"TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating CaMKII\u03b1 activity in the NAc","volume":"27","author":"Liu","year":"2022","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110523_bib34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-012-2681-5","article-title":"Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats","volume":"226","author":"Mahler","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110523_bib35","unstructured":"Mahoney CA-O, Cogswell A, Koralnik IJ, Scammell TE. The Neurobiological Basis of Narcolepsy. (1471-1548 (Electronic))."},{"key":"10.1016\/j.neuropharm.2025.110523_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.582147","article-title":"Drug-induced conditioned place preference and its practical use in substance use disorder research","volume":"14","author":"McKendrick","year":"2020","journal-title":"Front. Behav. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110523_bib37","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.tins.2021.09.002","article-title":"Orexin (hypocretin) and addiction","volume":"44","author":"Mehr","year":"2021","journal-title":"Trends Neurosci."},{"issue":"9 Pt A","key":"10.1016\/j.neuropharm.2025.110523_bib38","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.neubiorev.2013.05.002","article-title":"Using conditioned place preference to identify relapse prevention medications","volume":"37","author":"Napier","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110523_bib39","unstructured":"Narita M, Nagumo Y Fau - Hashimoto S, Hashimoto S Fau - Narita M, Narita M Fau - Khotib J, Khotib J Fau - Miyatake M, Miyatake M Fau - Sakurai T, Sakurai T Fau - Yanagisawa M, Yanagisawa M Fau - Nakamachi T, Nakamachi T Fau - Shioda S, Shioda S Fau - Suzuki T, Suzuki T. Direct Involvement of Orexinergic Systems in the Activation of the Mesolimbic Dopamine Pathway and Related Behaviors Induced by Morphine. (1529-2401 (Electronic))."},{"key":"10.1016\/j.neuropharm.2025.110523_bib40","unstructured":"Nepovimova E, Janockova J, Misik J, Kubik S, Stuchlik A, Vales K, Korabecny J, Mezeiova E, Dolezal R, Soukup O, Kobrlova T, Pham NL, Nguyen TD, Konecny J, Kuca KA-O. Orexin Supplementation in Narcolepsy Treatment: A Review. (1098-1128 (Electronic))."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110523_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.brainresbull.2008.09.014","article-title":"Activation of orexin\/hypocretin projections to basal forebrain and paraventricular thalamus by acute nicotine","volume":"77","author":"Pasumarthi","year":"2008","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110523_bib42","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1471-4159.2010.06666.x","article-title":"Stimulation of lateral hypothalamic glutamate and acetylcholine efflux by nicotine: implications for mechanisms of nicotine-induced activation of orexin neurons","volume":"113","author":"Pasumarthi","year":"2010","journal-title":"J. Neurochem."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2025.110523_bib43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2006.02.021","article-title":"Activation of orexin neurons by acute nicotine","volume":"535","author":"Pasumarthi","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110523_bib44","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1523\/JNEUROSCI.5724-09.2010","article-title":"Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior","volume":"30","author":"Plaza-Zabala","year":"2010","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110523_bib45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.biopsych.2011.06.025","article-title":"Hypocretin\/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal","volume":"71","author":"Plaza-Zabala","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110523_bib46","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/npp.2013.72","article-title":"A role for hypocretin\/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior","volume":"38","author":"Plaza-Zabala","year":"2013","journal-title":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110523_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113015","article-title":"Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: behavioural and neurochemical analyses","volume":"399","author":"Prajapati","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110523_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9763","article-title":"Current advances in research in treatment and recovery: nicotine addiction","volume":"5","author":"Prochaska","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2025.110523_bib49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2015.12.005","article-title":"Differential effects of intra-accumbal orexin-1 and -2 receptor antagonists on the expression and extinction of morphine-induced conditioned place preference in rats","volume":"142","author":"Sadeghzadeh","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110523_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112455","article-title":"Investigating the role of the amygdala orexin receptor 1 in memory acquisition and extinction in a rat model of PTSD","volume":"384","author":"Salehabadi","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"50","key":"10.1016\/j.neuropharm.2025.110523_bib51","doi-asserted-by":"crossref","first-page":"20260","DOI":"10.1073\/pnas.1320325110","article-title":"Orexin\/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus","volume":"110","author":"Sears","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2025.110523_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2018.11.032","article-title":"Orexin as a modulator of fear-related behavior: hypothalamic control of noradrenaline circuit","volume":"1731","author":"Soya","year":"2020","journal-title":"Brain Res."},{"issue":"36","key":"10.1016\/j.neuropharm.2025.110523_bib53","doi-asserted-by":"crossref","first-page":"14549","DOI":"10.1523\/JNEUROSCI.1130-13.2013","article-title":"Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear memory consolidation","volume":"33","author":"Soya","year":"2013","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110523_bib54","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-017-01782-z","article-title":"Orexin modulates behavioral fear expression through the locus coeruleus","volume":"8","author":"Soya","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110523_bib55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-012-2736-7","article-title":"The brain orexin system and almorexant in fear-conditioned startle reactions in the rat","volume":"223","author":"Steiner","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110523_bib56","unstructured":"Sun H, Palcza J, Card D, Gipson A, Rosenberg R, Kryger M, Lines C, Wagner JA, Troyer MD. Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep in Patients with Obstructive Sleep Apnea. (1550-9397 (Electronic))."},{"key":"10.1016\/j.neuropharm.2025.110523_bib57","unstructured":"Taslimi Z, Haghparast A Fau - Hassanpour-Ezatti M, Hassanpour-Ezatti M Fau - Safari M-S, Safari MS. Chemical Stimulation of the Lateral Hypothalamus Induces Conditioned Place Preference in Rats: Involvement of OX1 and CB1 Receptors in the Ventral Tegmental Area. (1872-7549 (Electronic))."},{"key":"10.1016\/j.neuropharm.2025.110523_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbr.2016.08.052","article-title":"Role of the orexin (hypocretin) system in contextual fear conditioning in rats","volume":"316","author":"Wang","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110523_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bja.2020.09.037","article-title":"Selective optogenetic activation of orexinergic terminals in the basal forebrain and locus coeruleus promotes emergence from isoflurane anaesthesia in rats","volume":"126","author":"Wang","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2025.110523_bib60","unstructured":"Wills L, Ables JL, Braunscheidel KM, Caligiuri SPB, Elayouby KS, Fillinger C, Ishikawa M, Moen JK, Kenny PJ. Neurobiological Mechanisms of Nicotine Reward and Aversion. (1521-1581 (Electronic))."},{"key":"10.1016\/j.neuropharm.2025.110523_bib61","unstructured":"Winrow CJ, Gotter Al Fau - Cox CD, Cox Cd Fau - Doran SM, Doran Sm Fau - Tannenbaum PL, Tannenbaum Pl Fau - Breslin MJ, Breslin Mj Fau - Garson SL, Garson Sl Fau - Fox SV, Fox Sv Fau - Harrell CM, Harrell Cm Fau - Stevens J, Stevens J Fau - Reiss DR, Reiss Dr Fau - Cui D, Cui D Fau - Coleman PJ, Coleman Pj Fau - Renger JJ, Renger JJ. Promotion of Sleep by Suvorexant-A Novel Dual Orexin Receptor Antagonist. (1563-5260 (Electronic))."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110523_bib62","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamapsychiatry.2016.3907","article-title":"Effect of selective inhibition of reactivated nicotine-associated memories with propranolol on nicotine craving","volume":"74","author":"Xue","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110523_bib63","unstructured":"Yazdi F, Jahangirvand M, Pirasteh AH, Moradi M, Haghparast A. Functional Interaction between OX2 and CB1 Receptors in the Ventral Tegmental Area and the Nucleus Accumbens in Response to Place Preference Induced by Chemical Stimulation of the Lateral Hypothalamus. (1873-5177 (Electronic))."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:34:13Z","timestamp":1748871253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825002291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":63,"alternative-id":["S0028390825002291"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110523","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of inhibiting the orexin system on nicotine reward memory and fear memory","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110523"}}